Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

29 Apr 2021 07:00

RNS Number : 9817W
Devro PLC
29 April 2021
 

Devro plc

 

Trading Update

 

Devro plc ("Devro" or the "Company"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 January 2021 to the current date ahead of its Annual General Meeting today.

Current trading

Q1 2021 edible collagen volumes increased 4.6% compared to the prior year driven by continued good underlying momentum and execution of our growth initiatives. Emerging markets were up 15% led by strong growth in China, South East Asia and Latin America. Mature markets were flat on the prior year, an improvement on the trends seen in 2020. Japan and North America both delivered strong growth but this was offset by lower demand in the UK & Ireland which had benefitted from elevated retail volumes in March 2020 as the pandemic took hold.

Financial position

The Group delivered strong cashflows during Q1, ending the quarter with comparable levels of leverage to 2020 year-end, including the dividend payment made in January 2021.

The Group repaid the US$25 million private placement due on the 19 April 2021 using a combination of available cash resources and RCF drawings. Post this repayment the Group maintains significant liquidity but with a lower average cost of borrowing.

The Group's remaining debt facilities consist of a committed £105 million Revolving Credit Facility (RCF), which expires in 2023, and US$75 million of private placements expiring April 2024 (US$50 million) and 2026 (US$25 million).

Outlook

We are encouraged by the good volume growth performance in Q1 and, whilst we expect this trend to continue we remain mindful of the uncertainties arising from the ongoing COVID-19 pandemic and likely foreign exchange headwinds. As a result, our expectations for 2021 remain unchanged.

ENDS 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Rohan Cummings

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain

Nick Hasell

Tel: 020 3727 1340

 

Dividend: In the Company's announcement on 2 March 2021 of its results for the year ended 31 December 2020, the Board proposed a final dividend of 6.3p per share (the "2020 Final Dividend") to be paid on 1 October 2021, to those shareholders on the register at 20 August 2021, subject to shareholder approval at the Annual General Meeting in April 2021. The Board has subsequently resolved to recommend the payment of the 2020 Final Dividend be brought forward from 1 October 2021 to 20 July 2021, to those shareholders on the register at 11 June 2021.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEFFWAEFSEDL
Date   Source Headline
4th Mar 20147:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
24th Feb 20146:09 pmRNSHolding(s) in Company - Amendment
7th Feb 20143:54 pmRNSHolding(s) in Company
27th Jan 201411:06 amRNSHolding(s) in Company
24th Jan 20141:04 pmRNSHolding(s) in Company
31st Dec 201312:36 pmRNSDirector/PDMR Shareholding
28th Nov 20138:29 amRNSDirector/PDMR Shareholding
25th Nov 20132:13 pmRNSBlocklisting Interim Review
14th Nov 20137:00 amRNSInterim Management Statement
15th Oct 20139:28 amRNSNotification of IMS date and Capital Markets Event
27th Sep 20135:26 pmRNSHolding(s) in Company
12th Sep 20134:46 pmRNSDirector/PDMR Shareholding
30th Aug 201311:29 amRNSTotal Voting Rights
12th Aug 20135:12 pmRNSDirector/PDMR Shareholding
31st Jul 20137:00 amRNS2013 Interim Results
30th Jul 20137:00 amRNSAppointment of Non-Executive Director
22nd Jul 201311:21 amRNSBlocklisting Application
5th Jul 201312:57 pmRNSHolding(s) in Company
2nd Jul 201310:00 amRNSInterim Results Webcast Notification
24th Jun 20137:00 amRNSPre-close trading update
18th Jun 20134:27 pmRNSHolding(s) in Company
14th Jun 20139:30 amRNSNotification of Upcoming Updates
31st May 20135:00 pmRNSTotal Voting Rights
24th May 20135:00 pmRNSBlocklisting Six Monthly Return
13th May 20133:17 pmRNSDirector/PDMR Transaction
3rd May 20133:36 pmRNSDirector/PDMR Transaction
30th Apr 201312:47 pmRNSTotal Voting Rights
23rd Apr 20134:43 pmRNSDirectors Dealings
23rd Apr 20139:24 amRNSHolding(s) in Company
23rd Apr 20137:00 amRNSSite Visit
22nd Apr 201310:34 amRNSHolding(s) in Company
18th Apr 20135:21 pmRNSResults of Annual General Meeting
18th Apr 20137:00 amRNSIMS & AGM
11th Apr 20133:32 pmRNSHolding(s) in Company
5th Apr 20133:10 pmRNSBlocklisting Application
2nd Apr 20138:06 amRNSTotal Voting Rights
28th Mar 20132:43 pmRNSHolding(s) in Company
22nd Mar 20134:35 pmRNSHolding(s) in Company
19th Mar 20134:33 pmRNSDirector/PDMR Shareholding
15th Mar 20132:00 pmRNS2012 Annual Report
14th Mar 20135:10 pmRNSDirector/PDMR Shareholding
1st Mar 20133:48 pmRNSDirector/PDMR Shareholding
26th Feb 201311:44 amRNS2012 Final Dividend Record Date Amendment
26th Feb 20137:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
14th Jan 201312:29 pmRNSListing Rule 9.6.14(R) Disclosure
8th Jan 20132:25 pmRNSPreliminary Results Notification
21st Dec 20122:22 pmRNSAnnual Information Update
19th Dec 20125:31 pmRNSDirector/PDMR Shareholding
18th Dec 20128:59 amRNSListing Rule 9.6.14(R) Disclosure
23rd Nov 20128:53 amRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.